Report Detail
Global Colorectal Cancer Drugs Market Growth 2019-2024
- RnM2837269 |
- 29 January, 2019 |
- Global |
- 164 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this setting presents a good opportunity for development of effective treatments that can improve cure rates for resected patients.
According to this study, over the next five years the Colorectal Cancer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Colorectal Cancer Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Colorectal Cancer Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Colorectal Cancer Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
BRAF or MEK Inhibitors
Tyrosine Kinase (TKI) Inhibitors
Immunomodulators
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Radiotherapy
Chemotherapy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AB Science
Amgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Colorectal Cancer Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Colorectal Cancer Drugs market by identifying its various subsegments.
Focuses on the key global Colorectal Cancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Colorectal Cancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Colorectal Cancer Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Colorectal Cancer Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Colorectal Cancer Drugs Consumption 2014-2024
- 2.1.2 Colorectal Cancer Drugs Consumption CAGR by Region
- 2.2 Colorectal Cancer Drugs Segment by Type
- 2.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors
- 2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitors
- 2.2.3 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
- 2.2.4 BRAF or MEK Inhibitors
- 2.2.5 Tyrosine Kinase (TKI) Inhibitors
- 2.2.6 Immunomodulators
- 2.3 Colorectal Cancer Drugs Consumption by Type
- 2.3.1 Global Colorectal Cancer Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Colorectal Cancer Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Colorectal Cancer Drugs Sale Price by Type (2014-2019)
- 2.4 Colorectal Cancer Drugs Segment by Application
- 2.4.1 Radiotherapy
- 2.4.2 Chemotherapy
- 2.5 Colorectal Cancer Drugs Consumption by Application
- 2.5.1 Global Colorectal Cancer Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Colorectal Cancer Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Colorectal Cancer Drugs Sale Price by Application (2014-2019)
3 Global Colorectal Cancer Drugs by Players
- 3.1 Global Colorectal Cancer Drugs Sales Market Share by Players
- 3.1.1 Global Colorectal Cancer Drugs Sales by Players (2017-2019)
- 3.1.2 Global Colorectal Cancer Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Colorectal Cancer Drugs Revenue Market Share by Players
- 3.2.1 Global Colorectal Cancer Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Colorectal Cancer Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Colorectal Cancer Drugs Sale Price by Players
- 3.4 Global Colorectal Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Colorectal Cancer Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Colorectal Cancer Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Colorectal Cancer Drugs by Regions
- 4.1 Colorectal Cancer Drugs by Regions
- 4.1.1 Global Colorectal Cancer Drugs Consumption by Regions
- 4.1.2 Global Colorectal Cancer Drugs Value by Regions
- 4.2 Americas Colorectal Cancer Drugs Consumption Growth
- 4.3 APAC Colorectal Cancer Drugs Consumption Growth
- 4.4 Europe Colorectal Cancer Drugs Consumption Growth
- 4.5 Middle East & Africa Colorectal Cancer Drugs Consumption Growth
5 Americas
- 5.1 Americas Colorectal Cancer Drugs Consumption by Countries
- 5.1.1 Americas Colorectal Cancer Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Colorectal Cancer Drugs Value by Countries (2014-2019)
- 5.2 Americas Colorectal Cancer Drugs Consumption by Type
- 5.3 Americas Colorectal Cancer Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Colorectal Cancer Drugs Consumption by Countries
- 6.1.1 APAC Colorectal Cancer Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Colorectal Cancer Drugs Value by Countries (2014-2019)
- 6.2 APAC Colorectal Cancer Drugs Consumption by Type
- 6.3 APAC Colorectal Cancer Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Colorectal Cancer Drugs by Countries
- 7.1.1 Europe Colorectal Cancer Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Colorectal Cancer Drugs Value by Countries (2014-2019)
- 7.2 Europe Colorectal Cancer Drugs Consumption by Type
- 7.3 Europe Colorectal Cancer Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Colorectal Cancer Drugs by Countries
- 8.1.1 Middle East & Africa Colorectal Cancer Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Colorectal Cancer Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Colorectal Cancer Drugs Consumption by Type
- 8.3 Middle East & Africa Colorectal Cancer Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Colorectal Cancer Drugs Distributors
- 10.3 Colorectal Cancer Drugs Customer
11 Global Colorectal Cancer Drugs Market Forecast
- 11.1 Global Colorectal Cancer Drugs Consumption Forecast (2019-2024)
- 11.2 Global Colorectal Cancer Drugs Forecast by Regions
- 11.2.1 Global Colorectal Cancer Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Colorectal Cancer Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Colorectal Cancer Drugs Forecast by Type
- 11.8 Global Colorectal Cancer Drugs Forecast by Application
12 Key Players Analysis
- 12.1 AB Science
- 12.1.1 Company Details
- 12.1.2 Colorectal Cancer Drugs Product Offered
- 12.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AB Science News
- 12.2 Amgen
- 12.2.1 Company Details
- 12.2.2 Colorectal Cancer Drugs Product Offered
- 12.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Amgen News
- 12.3 Array BioPharma
- 12.3.1 Company Details
- 12.3.2 Colorectal Cancer Drugs Product Offered
- 12.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Array BioPharma News
- 12.4 Bayer
- 12.4.1 Company Details
- 12.4.2 Colorectal Cancer Drugs Product Offered
- 12.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Bayer News
- 12.5 Boehringer Ingelheim
- 12.5.1 Company Details
- 12.5.2 Colorectal Cancer Drugs Product Offered
- 12.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Boehringer Ingelheim News
- 12.6 Bristol-Myers Squibb
- 12.6.1 Company Details
- 12.6.2 Colorectal Cancer Drugs Product Offered
- 12.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Bristol-Myers Squibb News
- 12.7 Elli Lilly
- 12.7.1 Company Details
- 12.7.2 Colorectal Cancer Drugs Product Offered
- 12.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Elli Lilly News
- 12.8 Roch
- 12.8.1 Company Details
- 12.8.2 Colorectal Cancer Drugs Product Offered
- 12.8.3 Roch Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Roch News
- 12.9 Hutchison MediPharma
- 12.9.1 Company Details
- 12.9.2 Colorectal Cancer Drugs Product Offered
- 12.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Hutchison MediPharma News
- 12.10 Merck & Co., Inc.
- 12.10.1 Company Details
- 12.10.2 Colorectal Cancer Drugs Product Offered
- 12.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Merck & Co., Inc. News
- 12.11 Mologen
- 12.12 Regeneron
- 12.13 Sanofi
- 12.14 Sumitomo Dainippon
- 12.15 Taiho Pharmaceutical
- 12.16 Vaccinogen
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Colorectal Cancer Drugs . Industry analysis & Market Report on Colorectal Cancer Drugs is a syndicated market report, published as Global Colorectal Cancer Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Colorectal Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
